fotos subir_TORRE 55 - MANUEL SUREDA - B (1)fotos subir_TORRE 55 - MANUEL SUREDA - B (1)

Manuel Sureda González

MEDICAL ONCOLOGY SPECIALIST
Medical oncology
See more specialists on Alicantealicante

en/medical-staff/oncologist

Dr. Manuel Sureda González is a renowned oncologist specializing in medical oncology , currently practicing at Hospital Quirón salud . His academic background includes a Bachelor of Medicine degree and a Doctorate in Medicine from the Universidad de Navarra. Throughout his career, he has made significant contributions to the field of oncology, notably his 2018 publication, "A novel genomic signature predicting FDG uptake in diverse metastatic tumors," in the journal EJNMMI Research. Dr. Sureda is also a member of the American Society of Clinical Oncology, reflecting his commitment to research and advancing cancer treatment. His experience and dedication have established him as a respected figure in the medical community, contributing to the development of innovative and personalized treatments for cancer patients.

Key information

  • Latest Publication:
    A novel genomic signature predicting FDG uptake in diverse metastatic tumors.

Professional Details

Hospital Quirónsalud Torrevieja
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
May 2002 - Present
Hospital Universitario General De Catalunya
Responsible
January 1993 - January 2002
Hospital Universitario General De Catalunya
Head of service
January 1993 - January 2002
Cleveland Clinic Foundation
Resident Physician
January 1991 - January 1991
Clínica Universidad de Navarra
Resident Physician
January 1986 - January 1989
Study
Bachelor of Medicine
Universidad de Navarra
1985
Doctorate
Universidad de Navarra
1991
Specialized Healthcare Training
Medical Oncology
Another qualification
ECFGM Certification
Another qualification
Expert in Immuno-Oncology, 3rd Edition
A novel genomic signature predicting FDG uptake in diverse metastatic tumors.
Article
Cancer immunotherapy with cytokine-induced killer cells.
Article
Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study.
Article
Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question.
Journal Article, Review
Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma.
Journal Article
Gene expression profiling of tumors from heavily pretreated patients with metastatic cancer for the selection of therapy: a pilot study.
Article
Photodynamic therapy in the treatment of brain tumours. A feasibility study.
Article
Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study.
Journal Article
Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies.
Journal Article, Review
Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study.
Journal Article
Therapeutic Drug Monitoring of Erlotinib in Non-Small Cell Lung Carcinoma: A Case Study.
Journal Article
Therapeutic drug monitoring of nivolumab in routine clinical practice. A pilot study.
Journal Article
Make an appointment with this professional